longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

ANN

ANN
----

LongbridgeAI

Why Ansell (ASX:ANN) Is Up 16.6% After Strong FY26 Earnings And Expanded Capital Returns Program

Simplywall
Aug 25, 2026 at 09:33 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Ansell Limited reported strong FY26 results with sales of US$2,140.2 million and net income of US$208.6 million. The company completed a A$118.4 million share buyback and announced a US$0.415 dividend for the half-year ended June 30, 2026. Management extended the repurchase program to September 6, 2027, signaling confidence in its financial position despite ongoing risks from rising input costs and competitive pressures.

  • Ansell Limited has reported full-year 2026 results showing higher sales of US$2,140.2 million and net income of US$208.6 million, alongside completing a A$118.4 million buyback of 3,957,877 shares and announcing a US$0.415 dividend for the half year ended June 30, 2026.
  • The combination of stronger profitability, ongoing capital returns through buybacks and dividends, and an extended repurchase program to September 6, 2027, highlights management’s confidence in the company’s financial position and capital allocation priorities.
  • Now, we’ll examine how Ansell’s strong full-year earnings and completed share buyback inform and potentially reshape its existing investment narrative.

Uncover the next big thing with 55 elite penny stocks that balance risk and reward.

Ansell Investment Narrative Recap

To own Ansell, you need to believe it can translate its global PPE footprint into steady earnings while managing cost and competitive pressures. The latest full year result and capital management updates support the existing short term focus on margin resilience, but they do not materially change the key risk around rising input costs and pricing pressure in increasingly commoditised product lines.

The most relevant announcement here is the completion of the A$118.4 million buyback of 3,957,877 shares alongside the extension of the repurchase program to September 6, 2027. For investors, this sits alongside higher net income and the increased US$0.415 dividend as part of the same capital allocation story, which will matter if raw material cost pressures or lower cost competitors start to test Ansell’s ability to sustain its improved profitability.

Yet against these stronger earnings and capital returns, investors should still be aware of the risk that rising sustainability expectations could...

Read the full narrative on Ansell (it's free!)

Ansell’s narrative projects $2.4 billion revenue and $258.2 million earnings by 2029. This requires 3.8% yearly revenue growth and roughly a $49.6 million earnings increase from $208.6 million today.

Uncover how Ansell's forecasts yield a A$37.06 fair value, a 10% downside to its current price.

Exploring Other Perspectives

ASX:ANN 1-Year Stock Price Chart

Four fair value estimates from the Simply Wall St Community span roughly A$34.10 to A$61.44, showing how far apart individual views on Ansell can be. You may want to weigh these against the risk that higher raw material costs and tougher price competition could pressure margins and, in turn, affect how sustainable the recent profit improvement really is.

Explore 4 other fair value estimates on Ansell - why the stock might be worth 18% less than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

  • A great starting point for your Ansell research is our analysis highlighting 4 key rewards that could impact your investment decision.
  • Our free Ansell research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Ansell's overall financial health at a glance.

Ready For A Different Approach?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

  • AI is about to change healthcare. These 7 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
  • Find 14 companies with promising cash flow potential yet trading below their fair value.
  • Explore 24 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Login to unlock4,211characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Ansell Limited

Ansell Limited

ANN.AU

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--